Ticker

Analyst Price Targets — ATS

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
March 26, 2024 3:14 amJoe RitchieGoldman Sachs$34.00$36.85StreetInsider Goldman Sachs Starts ATS Corp (ATS) at Sell

Latest News for ATS

Fusemachines Expands Access to Agentic AI for Talent Acquisition Through Broad ATS Connectivity

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Fusemachines Inc. (NASDAQ: FUSE), a leading provider of enterprise AI products and services, today announced expanded enterprise access to its Agentic AI for Talent Acquisition platform through new connectivity with more than 30 enterprise applicant tracking systems (ATS), enabling Fusemachines Agents to work directly within the systems organizations already use to manage…

GlobeNewsWire • Jun 18, 2026
New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF

Not intended for UK and US audiences  Nerandomilast long-term survival modeling presented at American Thoracic Society (ATS) 2026 and European Alliance of Associations for Rheumatology (EULAR) 2026 international congresses. Based on the modeling, nerandomilast consistently increased median survival in both idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF).1,2 Modeling predicts meaningful…

GlobeNewsWire • Jun 18, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for ATS.

No Senate trades found for ATS.

No House trades found for ATS.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top